Shanna Jackson joined Immatics as the Senior Director of Clinical Operations in April 2019 and leads the team responsible for the planning and execution of clinical trials for the Immatics portfolio (ACTolog, ACTengine, and ACTallo).
Prior to joining Immatics, Shanna served as the Director of Clinical Operations at Lexicon Pharmaceuticals. In addition to her contributions to numerous IND submissions across multiple therapeutic areas, Shanna had the privilege of leading the team responsible for telotristat ethyl (Xermelo®), Lexicon’s first approved product. She was actively involved in the development of the program in an orphan Oncology indication from IND to post-market life-cycle management. Today, she looks forward to the next contribution that will improve patient’s treatment options and quality of life.
Shanna Jackson holds a Bachelor degree in Biomedical Science from Texas A&M University, a Master’s Degree in Business Administration with a specialty in Human Resources, and is a registered nurse.